National Jewish Health: Cystic Fibrosis trials
The registry lists 22 Cystic Fibrosis studies with National Jewish Health as lead sponsor. 4 are open to participants now and 8 have results posted.
Phase 1 3Phase 2 6Phase 3 1Phase 4 1No phase 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Mycobacteriophage Treatment of Non-tuberculosis MycobacteriaEnrolling by invitationNCT06262282
- Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographYEnrolling by invitationNCT05822102
- PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic FibrosisEnrolling by invitationNCT02419989
- PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic FibrosisEnrolling by invitationNCT02073409
- Sildenafil Exercise: Role of PDE5 InhibitionCompletedNCT04039087Phase 2/3Results posted
- : TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)CompletedNCT03445793Results posted
- IV Colistin for Pulmonary Exacerbations: Improving Safety and EfficacyCompletedNCT02918409Phase 4Results posted
- Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CFCompletedNCT02626182Phase 1/2Results posted
- Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)TerminatedNCT02323100Phase 1/2Results posted
- Effects of Sildenafil on CFTR-dependent Ion Transport ActivityCompletedNCT01132482Phase 2Results posted
- Phase II Study of Digitoxin to Treat Cystic FibrosisCompletedNCT00782288Phase 2Results posted
- Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00659529Phase 1/2Results posted
- T Cell Memory Fuels the Innate Response in Chronic CF Lung DiseaseCompletedNCT04397861
- Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic FibrosisCompletedNCT04397809
- Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary ExacerbationsCompletedNCT04354038
- Observational Trial of the Longitudinal Effects of CFTR Modulator DrugsCompletedNCT04353752
- Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary ExacerbationsCompletedNCT04341532
- Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.CompletedNCT04038710
- Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic FibrosisCompletedNCT04024423
- Telehealth Cognitive Behavioral Stress Management for Adults With Cystic FibrosisCompletedNCT03560726Not applicable
- Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine SolutionCompletedNCT01736839
- Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel TherapiesCompletedNCT00727285